197 related articles for article (PubMed ID: 33666514)
1.
Zhu Y; Pu Z; Wang G; Li Y; Wang Y; Li N; Peng F
Biomark Med; 2021 Apr; 15(5):373-384. PubMed ID: 33666514
[TBL] [Abstract][Full Text] [Related]
2. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.
Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY
Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
[TBL] [Abstract][Full Text] [Related]
4. FAM3C in Cancer-Associated Adipocytes Promotes Breast Cancer Cell Survival and Metastasis.
Kim S; Oh J; Park C; Kim M; Jo W; Kim CS; Cho SW; Park J
Cancer Res; 2024 Feb; 84(4):545-559. PubMed ID: 38117489
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of factors related to FAM3C/ILEI dimerization and identification of inhibitor candidates targeting cancer treatment.
Flores RMA; Pantaleão SQ; Araujo SC; Malpartida HMG; Honorio KM
Comput Biol Chem; 2023 Jun; 104():107869. PubMed ID: 37068312
[TBL] [Abstract][Full Text] [Related]
6. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of FAM3C in esophageal squamous cell carcinoma.
Zhu YH; Zhang B; Li M; Huang P; Sun J; Fu J; Guan XY
Diagn Pathol; 2015 Oct; 10():192. PubMed ID: 26498278
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.
Ma Y; Shi J; Liu Y; Cui W; Pan R; Qiu H; Han F; Hou N; Sun X
Crit Rev Eukaryot Gene Expr; 2023; 33(4):39-52. PubMed ID: 37183945
[TBL] [Abstract][Full Text] [Related]
9. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Yang W; Feng B; Meng Y; Wang J; Geng B; Cui Q; Zhang H; Yang Y; Yang J
J Cell Mol Med; 2019 May; 23(5):3464-3475. PubMed ID: 30887707
[TBL] [Abstract][Full Text] [Related]
10. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
11. Fam3c modulates osteogenic differentiation by down-regulating Runx2.
Bendre A; Büki KG; Määttä JA
Differentiation; 2017; 93():50-57. PubMed ID: 27914282
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
13. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1.
Jin LL; Zhang SJ; Lu GX; Lv F; Shang R; Yang J
Kaohsiung J Med Sci; 2020 May; 36(5):318-327. PubMed ID: 31880039
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of FAM3C protein as a novel biomarker for epithelial-mesenchymal transition and poor outcome in gastric cancer.
Yin S; Chen F; Ye P; Yang G
Int J Clin Exp Pathol; 2018; 11(8):4247-4256. PubMed ID: 31949820
[TBL] [Abstract][Full Text] [Related]
15. FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes.
Zhang X; Yang W; Wang J; Meng Y; Guan Y; Yang J
Metabolism; 2018 Apr; 81():71-82. PubMed ID: 29221790
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.
Jansson AM; Csiszar A; Maier J; Nyström AC; Ax E; Johansson P; Schiavone LH
J Biol Chem; 2017 Sep; 292(37):15501-15511. PubMed ID: 28751379
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
18. uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy.
Lund IK; Illemann M; Thurison T; Christensen IJ; Høyer-Hansen G
Curr Drug Targets; 2011 Nov; 12(12):1744-60. PubMed ID: 21707477
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization and expression analysis of the murine Fam3c gene.
Pilipenko VV; Reece A; Choo DI; Greinwald JH
Gene; 2004 Jun; 335():159-68. PubMed ID: 15194199
[TBL] [Abstract][Full Text] [Related]
20. Tumor invasion and oxidative stress: biomarkers and therapeutic strategies.
Muinelo-Romay L; Alonso-Alconada L; Alonso-Nocelo M; Barbazan J; Abal M
Curr Mol Med; 2012 Jul; 12(6):746-62. PubMed ID: 22292441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
